SLC5A4 and atherosclerosis: Genetic variations influence gut microbiome composition, which in turn affects lipid metabolism and blood pressure regulation. Genetic mutations in sodium transporters and lipid metabolism genes alter microbial communities, impacting CVD risks like hypertension and atherosclerosis.